Biphasic effect of aspirin on apoptosis of bovine vascular endothelial cells and its molecular mechanism

Acta Pharmacologica Sinica

Volumn 28, Issue 3, 2007, Pages 353-358

  Chen, Qing Quan ^a   Liu, Wen Lan ^a   Guo, Xun ^a   Li, Yuan Jian ^a   Guo, Zhao Gui ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Apoptosis; Aspirin; Endothelial cells; Hydroperoxide; Mitogen activated protein kinase

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; ACETYLSALICYLIC ACID; DNA FRAGMENT; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE P38;

AGAR GEL ELECTROPHORESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; COW; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FLUORESCENCE MICROSCOPE; NONHUMAN; PROTEIN EXPRESSION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; ASPIRIN; CATTLE; CELL SURVIVAL; CELLS, CULTURED; CYCLOOXYGENASE INHIBITORS; DNA; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; P38 MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 33847203677     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2007.00518.x     Document Type: Article

References (24)

1. Rodondi N, Cornuz J, Bauer DC. Aspirin for the primary prevention of cardiovascular disease: a comprehensive review. Compr Ther 2005; 31: 186-93.
2. Zandi PP, Anthony JC, Hayden KM, Mehta K, Mayer L, Breitner JC. Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study. Neurology 2002; 59: 880-6.
3. Gill S, Sinicrope FA. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure? Semin Oncol 2005; 32: 24-34.
4. Schror K. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis. Semin Thromb Hemost 1997; 23: 349-56.
5. Liu JF, Jamieson GG, Drew PA, Zhu GJ, Zhang SW, Zhu TN, et al. Aspirin induces apoptosis in oesophageal cancer cells by inhibiting the pathway of NF-kappaB downstream regulation of cyclooxygenase-2. ANZ J Surg 2005; 75: 1011-6.
6. Czyz M, Watala C. Aspirin-the prodigious panacea? Molecular mechanisms of the action of acetylsalicylic acid in the organism. Postepy Hig Med Dosw 2005; 59: 105-15.
7. Grosser N, Schroder H. Aspirin protects endothelial cells from oxidant damage via the nitric oxide-cGMP pathway. Arterioscler Thromb Vasc Biol 2003; 23: 1345-51.
8. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-57.
9. Cullen P, Rauterberg J, Lorkowski S. The pathogenesis of atherosclerosis. Handb Exp Pharmacol 2005; 170: 3-70.
10. Cao Y. Tumor angiogenesis and therapy. Biomed Pharmacother 2005; 59 Suppl 2: S340-3.
11. Sumbayev VV, Yasinska IM. Regulation of MAP kinase-dependent apoptotic pathway: implication of reactive oxygen and nitrogen species. Arch Biochem Biophys 2005; 436: 406-12.
12. Mifflin RC, Saada JI, Di Mari JF, Valentich JD, Adegboyega PA, Powell DW. Aspirin-mediated COX-2 transcript stabilization via sustained p38 activation in human intestinal myofibroblasts. Mol Pharmacol 2004; 65: 470-8.
13. Abiru S, Nakao K, Ichikawa T, Migita K, Shigeno M, Sakamoto M, et al. Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells. Hepatology 2002; 35: 1117-24.
14. Mehta JL, Chen J, Yu F, Li DY. Aspirin inhibits ox-LDL-mediated LOX-1 expression and metalloproteinase-1 in human coronary endothelial cells. Cardiovasc Res 2004; 64: 243-9.
15. Han YF, Su CJ, Ou BR. The effect and mechanism of felodipine and valsartan on a novel salt-sensitive hypertensive rat induced by sensory denervation. Chin J Cardiol 2005; 33: 255-9. Chinese.
16. 2-induced apoptosis in bovine aortic endothelial cells. Acta Pharmacol Sin 2000; 21: 991-6.
17. Ashktorab H, Dawkins FW, Mohamed R, Larbi D, Smoot DT. Apoptosis induced by aspirin and 5-fluorouracil in human colonic adenocarcinoma cells. Dig Dis Sci 2005; 50: 1025-32.
18. Benamouzig R, Uzzan B, Little J, Chaussade S. Low dose aspirin, COX-inhibition and chemoprevention of colorectal cancer. Curr Top Med Chem 2005; 5: 493-503.
19. Teh SH, Hill AK, Foley DA, McDermott EW, O'Higgins NJ, Young LS. COX inhibitors modulate bFGF-induced cell survival in MCF-7 breast cancer cells. J Cell Biochem 2004; 91: 796-807.
20. Costanzo A, Moretti F, Burgio VL, Bravi C, Guido F, Levrero M, et al. Endothelial activation by angiotensin II through NFkappaB and p38 pathways: Involvement of NF-kappaB-inducible kinase (NIK), free oxygen radicals, and selective inhibition by aspirin. J Cell Physiol 2003; 195: 402-10.
21. Vartiainen N, Goldsteins G, Keksa-Goldsteine V, Chan PH, Koistinaho J. Aspirin inhibits p44/42 mitogen-activated protein kinase and is protective against hypoxia/reoxygenation neuronal damage. Stroke 2003; 34: 752-7.
22. Ordan O, Rotem R, Jaspers I, Flescher E. Stress-responsive JNK mitogen-activated protein kinase mediates aspirin-induced suppression of B16 melanoma cellular proliferation. Br J Pharmacol 2003; 138: 1156-62.
23. Liu WL, Guo X, Chen QQ, Guo ZG. Opposing effect of p38 CCDPK and p44/42 CCDPK signaling on TNF-alpha-induced apoptosis in bovine aortic endothelial cells. Acta Pharmacol Sin 2001; 22: 405-10.
24. Alonso G, Ambrosino C, Jones M, Nebreda AR. Differential activation of p38 mitogen-activated protein kinase isoforms depending on signal strength. J Biol Chem 2000; 275: 40641-8.